Fishawack Health, a UK-based global commercialisation partner for the modern life science era, announced on Tuesday that it has named Jonathan (Jon) Koch as its new chief executive officer.
In the new role, Koch is to lead Fishawack Health through its next stage of growth, which is focused on building and retaining talented teams and delivering a complete set of integrated services for customers across the life science industry.
Koch has spent his complete career in the healthcare sector, including around 12 years at Covance as group president of Clinical Development and Commercialisation services. He has served as senior vice president and CEO of Global Dental at Henry Schein.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business